143 related articles for article (PubMed ID: 32861704)
1. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients.
Onal C; Ozyigit G; Guler OC; Hurmuz P; Torun N; Tuncel M; Dolek Y; Yedekci Y; Oymak E; Tilki B; Akyol F
Radiother Oncol; 2020 Oct; 151():222-227. PubMed ID: 32861704
[TBL] [Abstract][Full Text] [Related]
2. Potential Impact of
Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG
J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978
[TBL] [Abstract][Full Text] [Related]
3. PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
Schiller K; Stöhrer L; Düsberg M; Borm K; Devecka M; Vogel MME; Tauber R; Heck MM; Rauscher I; Eiber M; Gschwend JE; Duma MN; Combs SE
Eur Urol Oncol; 2021 Feb; 4(1):73-83. PubMed ID: 32451312
[TBL] [Abstract][Full Text] [Related]
4. Impact of
Schiller K; Devecka M; Maurer T; Eiber M; Gschwend J; Schwaiger M; Combs SE; Habl G
Radiat Oncol; 2018 Mar; 13(1):36. PubMed ID: 29490670
[TBL] [Abstract][Full Text] [Related]
5.
Vinsensia M; Chyoke PL; Hadaschik B; Holland-Letz T; Moltz J; Kopka K; Rauscher I; Mier W; Schwaiger M; Haberkorn U; Mauer T; Kratochwil C; Eiber M; Giesel FL
J Nucl Med; 2017 Dec; 58(12):1949-1955. PubMed ID: 28637799
[No Abstract] [Full Text] [Related]
6. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.
Vogel MME; Düsberg M; Stöhrer L; Dewes S; Sage EK; Borm KJ; Gschwend JE; Eiber M; Combs SE; Schiller K
Eur Urol Oncol; 2022 Dec; 5(6):668-676. PubMed ID: 36280446
[TBL] [Abstract][Full Text] [Related]
7. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
[TBL] [Abstract][Full Text] [Related]
8. Comparison of
Zhang Q; Zang S; Zhang C; Fu Y; Lv X; Zhang Q; Deng Y; Zhang C; Luo R; Zhao X; Wang W; Wang F; Guo H
J Transl Med; 2017 Nov; 15(1):230. PubMed ID: 29115970
[TBL] [Abstract][Full Text] [Related]
9. Mask R-CNN assisted 2.5D object detection pipeline of
Xu D; Ma M; Cao M; Kishan AU; Nickols NG; Scalzo F; Sheng K
Sci Rep; 2023 Jan; 13(1):1696. PubMed ID: 36717727
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
11. Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after
Schiller K; Sauter K; Dewes S; Eiber M; Maurer T; Gschwend J; Combs SE; Habl G
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1656-1662. PubMed ID: 28646463
[TBL] [Abstract][Full Text] [Related]
12.
Calais J; Czernin J; Cao M; Kishan AU; Hegde JV; Shaverdian N; Sandler K; Chu FI; King CR; Steinberg ML; Rauscher I; Schmidt-Hegemann NS; Poeppel T; Hetkamp P; Ceci F; Herrmann K; Fendler WP; Eiber M; Nickols NG
J Nucl Med; 2018 Feb; 59(2):230-237. PubMed ID: 29123013
[TBL] [Abstract][Full Text] [Related]
13. An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients.
Trapp C; Oliinyk D; Rogowski P; von Bestenbostel R; Ganswindt U; Li M; Eze C; Bartenstein P; Beyer L; Ilhan H; Sheikh G; Unterrainer L; Stief C; Westhofen T; Kunz WG; Unterrainer M; Belka C; Schmidt-Hegemann NS
J Nucl Med; 2023 Jun; 64(6):918-923. PubMed ID: 36732055
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
Freitag MT; Radtke JP; Hadaschik BA; Kopp-Schneider A; Eder M; Kopka K; Haberkorn U; Roethke M; Schlemmer HP; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):70-83. PubMed ID: 26508290
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
[No Abstract] [Full Text] [Related]
16. Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with
Yaxley JW; Raveenthiran S; Nouhaud FX; Samartunga H; Yaxley AJ; Coughlin G; Delahunt B; Egevad L; McEwan L; Wong D
J Urol; 2019 Apr; 201(4):815-820. PubMed ID: 30672842
[TBL] [Abstract][Full Text] [Related]
17. Comparison of
Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.
Maurer T; Weirich G; Schottelius M; Weineisen M; Frisch B; Okur A; Kübler H; Thalgott M; Navab N; Schwaiger M; Wester HJ; Gschwend JE; Eiber M
Eur Urol; 2015 Sep; 68(3):530-4. PubMed ID: 25957851
[TBL] [Abstract][Full Text] [Related]
19. Delineating sites of failure following post-prostatectomy radiation treatment using
Byrne K; Eade T; Kneebone A; Guo L; Hsiao E; Schembri G; Kwong C; Hunter J; Emmett L; Hruby G
Radiother Oncol; 2018 Feb; 126(2):244-248. PubMed ID: 29132644
[TBL] [Abstract][Full Text] [Related]
20. The accuracy of
Öbek C; Doğanca T; Demirci E; Ocak M; Kural AR; Yıldırım A; Yücetaş U; Demirdağ Ç; Erdoğan SM; Kabasakal L;
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1806-1812. PubMed ID: 28624849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
